Last month, AstraZeneca, Boehringer Ingelheim and GlaxoSmithKline all committed to capping the price of inhalers at $35 a month.
Full story here.
Published by spectrumlocalnews.com
Visited 1 times, 1 visit(s) today
April 3, 2024• byQuorum Call
Last month, AstraZeneca, Boehringer Ingelheim and GlaxoSmithKline all committed to capping the price of inhalers at $35 a month.